Bio-Techne Corporation (TECH)
NASDAQ · Healthcare
Bio-Techne Corporation Income Statement 2009–2025
| Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 1.22B | 1.16B | 1.14B | 1.11B | 931.0M | 738.7M | 714.0M | 643.0M | 563.0M | 499.0M | 452.2M | 357.8M | 310.6M | 314.6M | 290.0M | 269.0M | 264.0M |
| Gross Profit | 790.3M | 769.7M | 769.8M | 756.5M | 632.9M | 483.2M | 473.5M | 432.1M | 374.5M | 336.7M | 307.3M | 251.4M | 231.1M | 235.8M | 224.9M | 214.1M | 208.0M |
| Profitability | |||||||||||||||||
| Operating Income | 102.3M | 206.7M | 298.9M | 296.6M | 237.3M | 157.4M | 146.7M | 136.2M | 120.6M | 150.6M | 147.0M | 159.8M | 158,469 | 166.2M | 163.1M | 156.3M | 150.8M |
| EBITDA | 212.2M | 318.4M | 406.2M | 397.7M | 325.0M | 240.2M | 224.9M | 200.6M | 180.6M | 193.4M | 184.2M | 178.9M | 12.5M | 178.7M | 171.8M | 164.5M | 158.5M |
| Net Income | 73.4M | 168.1M | 285.3M | 272.1M | 140.4M | 229.3M | 96.1M | 126.2M | 76.1M | 104.5M | 107.7M | 110.9M | 112.6M | 112.3M | 112.3M | 109.8M | 105.2M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | $0.46 | $1.05 | $1.76 | $1.66 | $0.87 | $5.82 | $2.47 | $3.31 | $2.03 | $2.80 | $2.89 | $3.00 | $3.05 | $3.04 | $3.02 | $2.94 | $2.78 |
| Shares Outstanding (dil.) | 160M | 161M | 162M | 164M | 162M | 39M | 39M | 38M | 38M | 37M | 37M | 37M | 37M | 37M | 37M | 37M | 38M |
Bio-Techne Corporation Income Statement — FAQ
Bio-Techne Corporation (TECH) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TECH's income statement history?
The chart and table above show Bio-Techne Corporation's income statement by year and by quarter, including the growth rate.